Poxvirus encoded eIF2α homolog, K3 family proteins, is a key determinant of poxvirus host species specificity.
暂无分享,去创建一个
[1] Chorong Park,et al. Species‐specific inhibition of antiviral protein kinase R by capripoxviruses and vaccinia virus , 2019, Annals of the New York Academy of Sciences.
[2] Zev N. Kronenberg,et al. Emergence of a Viral RNA Polymerase Variant during Gene Copy Number Amplification Promotes Rapid Evolution of Vaccinia Virus , 2016, Journal of Virology.
[3] B. Moss,et al. Opposing Roles of Double-Stranded RNA Effector Pathways and Viral Defense Proteins Revealed with CRISPR-Cas9 Knockout Cell Lines and Vaccinia Virus Mutants , 2016, Journal of Virology.
[4] G. McFadden,et al. Myxoma virus M156 is a specific inhibitor of rabbit PKR but contains a loss-of-function mutation in Australian virus isolates , 2016, Proceedings of the National Academy of Sciences.
[5] A. Geballe,et al. Essential role of protein kinase R antagonism by TRS1 in human cytomegalovirus replication. , 2016, Virology.
[6] P. Earl,et al. Generation of Recombinant Vaccinia Viruses , 2015, Current protocols in microbiology.
[7] J. Kitzman,et al. Experimental Evolution Identifies Vaccinia Virus Mutations in A24R and A35R That Antagonize the Protein Kinase R Pathway and Accompany Collapse of an Extragenic Gene Amplification , 2015, Journal of Virology.
[8] Stefan Rothenburg,et al. Ectopic Expression of Vaccinia Virus E3 and K3 Cannot Rescue Ectromelia Virus Replication in Rabbit RK13 Cells , 2015, PloS one.
[9] Jay Shendure,et al. Adaptive Gene Amplification As an Intermediate Step in the Expansion of Virus Host Range , 2014, PLoS pathogens.
[10] Jay Shendure,et al. Poxviruses Deploy Genomic Accordions to Adapt Rapidly against Host Antiviral Defenses , 2012, Cell.
[11] G. McFadden,et al. Myxoma Virus M064 Is a Novel Member of the Poxvirus C7L Superfamily of Host Range Factors That Controls the Kinetics of Myxomatosis in European Rabbits , 2012, Journal of Virology.
[12] Jingxin Cao,et al. Comparative Analysis of Poxvirus Orthologues of the Vaccinia Virus E3 Protein: Modulation of Protein Kinase R Activity, Cytokine Responses, and Virus Pathogenicity , 2011, Journal of Virology.
[13] B. Moss,et al. Genome-Wide Analysis of the 5′ and 3′ Ends of Vaccinia Virus Early mRNAs Delineates Regulatory Sequences of Annotated and Anomalous Transcripts , 2011, Journal of Virology.
[14] H. Baker,et al. Roles of Vaccinia Virus Genes E3L and K3L and Host Genes PKR and RNase L during Intratracheal Infection of C57BL/6 Mice , 2010, Journal of Virology.
[15] M. Esteban,et al. The interferon system and vaccinia virus evasion mechanisms. , 2009, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[16] Jingxin Cao,et al. Vaccinia Virus E3 Suppresses Expression of Diverse Cytokines through Inhibition of the PKR, NF-κB, and IRF3 Pathways , 2009, Journal of Virology.
[17] K. Dittmar,et al. Rapid evolution of protein kinase PKR alters sensitivity to viral inhibitors , 2008, Nature Structural &Molecular Biology.
[18] Nels C. Elde,et al. Protein kinase R reveals an evolutionary model for defeating viral mimicry , 2008, Nature.
[19] Jingxin Cao,et al. Antagonizing activity of vaccinia virus E3L against human interferons in Huh7 cells. , 2008, Virology.
[20] Arvin C. Dar,et al. Higher-Order Substrate Recognition of eIF2α by the RNA-Dependent Protein Kinase PKR , 2005, Cell.
[21] F. Sicheri,et al. X-ray crystal structure and functional analysis of vaccinia virus K3L reveals molecular determinants for PKR subversion and substrate recognition. , 2002, Molecular cell.
[22] J. Langland,et al. The role of the PKR-inhibitory genes, E3L and K3L, in determining vaccinia virus host range. , 2002, Virology.
[23] D. Tscharke,et al. The Vaccinia Virus Superoxide Dismutase-Like Protein (A45R) Is a Virion Component That Is Nonessential for Virus Replication , 2001, Journal of Virology.
[24] K. Ozato,et al. Pseudosubstrate inhibition of protein kinase PKR by swine pox virus C8L gene product. , 2000, Virology.
[25] G. McFadden,et al. The complete DNA sequence of myxoma virus. , 1999, Virology.
[26] B. Moss,et al. Compact, synthetic, vaccinia virus early/late promoter for protein expression. , 1997, BioTechniques.
[27] J. Silverman,et al. Regulation of the protein kinase PKR by the vaccinia virus pseudosubstrate inhibitor K3L is dependent on residues conserved between the K3L protein and the PKR substrate eIF2alpha , 1997, Molecular and cellular biology.
[28] M. Katze,et al. Interaction of the interferon-induced PKR protein kinase with inhibitory proteins P58IPK and vaccinia virus K3L is mediated by unique domains: implications for kinase regulation , 1996, Molecular and cellular biology.
[29] E. Paoletti,et al. Distinct patterns of IFN sensitivity observed in cells infected with vaccinia K3L- and E3L- mutant viruses. , 1995, Virology.
[30] O. Elroy-Stein,et al. Recombinant vaccinia virus K3L gene product prevents activation of double-stranded RNA-dependent, initiation factor 2 alpha-specific protein kinase. , 1993, The Journal of biological chemistry.
[31] H. W. Chang,et al. The E3L and K3L vaccinia virus gene products stimulate translation through inhibition of the double-stranded RNA-dependent protein kinase by different mechanisms , 1993, Journal of virology.
[32] O. Elroy-Stein,et al. The vaccinia virus K3L gene product potentiates translation by inhibiting double-stranded-RNA-activated protein kinase and phosphorylation of the alpha subunit of eukaryotic initiation factor 2 , 1992, Journal of virology.
[33] E. Paoletti,et al. Vaccinia virus-encoded elF-2α homolog abrogates the antiviral effect of interferon , 1991 .
[34] B. Williams,et al. Structure and function of the protein kinase R. , 2007, Current topics in microbiology and immunology.